Organogenesis Holdings (ORGO) EBT (2016 - 2026)

Organogenesis Holdings' EBT history runs 11 years deep, the most recent figure standing at -$68.5 million for Q1 2026.

• On a quarterly basis, EBT fell 165.57% year-over-year to -$68.5 million in Q1 2026; TTM through Mar 2026 was $4.3 million, a 117.65% increase from a year earlier, with the FY2025 full-year figure at $47.0 million, up 1773.32% from the prior year.
• EBT declined to -$68.5 million in Q1 2026 per ORGO's latest filing, from $63.4 million in the prior quarter.
• Across five years, EBT topped out at $63.4 million in Q4 2025 and bottomed at -$68.5 million in Q1 2026.
• The 5-year median for EBT is $1.2 million (2022), against an average of $374411.8.
• Across the five-year window, EBT surged 670.88% in 2024 and plunged 493.67% in 2025, its largest moves.
• Year by year, EBT stood at $8.8 million in 2022, then tumbled by 120.52% to -$1.8 million in 2023, then jumped by 670.88% to $10.3 million in 2024, then soared by 518.62% to $63.4 million in 2025, then sank by 207.96% to -$68.5 million in 2026.
• Per Business Quant, the three latest ORGO EBT figures stand at -$68.5 million (Q1 2026), $63.4 million (Q4 2025), and $21.2 million (Q3 2025).